Document Detail


Influence of natural and synthetic histone deacetylase inhibitors on chromatin.
MedLine Citation:
PMID:  22229817     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Histone deacetylase inhibitors (HDACI) have emerged as a new class of anticancer therapeutics. The hydroxamic acid, suberoylanilide hyroxamic acid (Vorinostat, Zolinza™) and the cyclic peptide, depsipeptide (Romidepsin, Istodax™) were approved by the US Food and Drug Administration (FDA) for the treatment of cutaneous T-cell lymphoma in 2006 and 2009, respectively. At least 15 HDACI are currently undergoing clinical trials either alone or in combination with other therapeutic modalities for the treatment of numerous hematological and solid malignancies. Further, the potential utility of HDACI has been extended to non-oncologic applications including auto-immune disorders, inflammation, diseases of the central nervous system and malaria. Given the promise of HDACI, there is growing interest in the potential of dietary compounds that possess HDAC inhibition activity. This review is focused on the identification of and recent findings with HDACI from dietary, medicinal plant and microbial sources. We discuss the mechanisms of action and clinical potential of natural HDACI.
Authors:
Paul V Licciardi; Faith Aa Kwa; Katherine Ververis; Natasha Di Costanzo; Aneta Balcerczyk; Mimi L Tang; Assam El-Osta; Tom Karagiannis
Related Documents :
3294257 - Nonesterified fatty acids and glucose in lactating dairy cows: diurnal variations and c...
21834227 - On the isomerization of ent-kaurenic acid.
10355027 - Fatty acid trafficking in the adipocyte.
2991257 - Effects of fatty acids on na+-ca2+ exchange and ca2+ permeability of cardiac sarcolemma...
16664387 - Effect of calmodulin antagonists on auxin-induced elongation.
3970197 - Intestinal triglycerides are derived from both endogenous and exogenous sources.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-9
Journal Detail:
Title:  Antioxidants & redox signaling     Volume:  -     ISSN:  1557-7716     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888899     Medline TA:  Antioxid Redox Signal     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Parkville, Victoria, Australia; paul.licciardi@mcri.edu.au.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interactive Effects of Approach Motivational Intensity and Alcohol Cues on the Scope of Perceptual A...
Next Document:  Analysis of Risk Factors Associated with Antibiotic-Resistant Escherichia coli.